Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients

Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients

US Patent 10556932 · Granted Feb 11, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bio2024
Codon optimization for increasing transgene expression in chloroplasts of higher2022
Compositions and methods for inhibiting biofilm deposition and production2022
Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bio2022
Compositions and methods for delivery of bioencapsulated proteins across blood-b2021
Compositions and methods thereof for down-regulation of genes following oral del2021
Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treat2020
Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bio2020
Chloroplasts engineered to express pharmaceutical proteins in edible plants2020
Expression of β-mannanase in chloroplasts and its utilization in lignocellulosic2020
Production and use of plant degrading materials2020
Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bio2019